Greece
Menu

VITAPCRTM PLATFORM

Tests available for the VitaPCR ™ platform: 


SARS-CoV-2 Rapid molecular diagnostic test using Real Time PCR technology for the semiquantitative detection of viral RNA in nasopharyngeal (RF) and oropharyngeal (OF) swabs taken from patients with signs and symptoms of respiratory infection. The test can provide an infection response for SARS-CoV-2. Execution time about 20 minutes with analytical sensitivity of about 90 viral copies / reaction

Flu A&B Rapid molecular diagnostic test using Real Time PCR technology for the semiquantitative detection and discrimination of influenza A and B viral RNA in nasal and nasopharyngeal swabs obtained from patients with signs and symptoms of respiratory infection. Execution time about 20 minutes with analytical sensitivity of about 10 copies /reaction

Combo SARS CoV-2 + Flu AB Combined rapid molecular diagnostic test using Real Time PCR technology for semiquantitative detection and simultaneous discrimination of influenza A and B viral RNA and SARS CoV-2 in nasal and nasopharyngeal swabs obtained by patients with signs and symptoms of respiratory infection. Run time less than 20 minutes with analytical sensitivity of approximately 10 copies /reaction for influenza and 45 copies/reaction for SARS CoV-2 


Real Time PCR SARS-CoV-2 Assay

EASY

  • Simple 1min hands-on time preparation
  • Minimal training required for operation
  • Automated result interpretation

RAPID

  • Sample to result in 20min
  • Process more samples in less time
  • Improved patient management and triage

VERSATILE

  • Can be deployed anywhere
  • No additional equipment needed
  • Room temperature storage – tests ready for use


Catalog No. Qty Description
51572 1 VitaPCR™ Instrument
51574 20 VitaPCR™ SARS-CoV-2 assay
51573 20 VitaPCR™ Flu A&B assay


GENERAL DIAGNOSTIC PROCEDURE

RESULT INTERPRETATION


For more information, visit www.credodxbiomed.com

Our values

10 core values have influenced the progress of our group.

READ MORE »